Servier Executive: ‘We Are Not Looking for Blockbusters, We’re Looking for Innovative Science’News DeskJune 30, 20260 It’s been a busy few months for Servier, which followed its $2.5 billion acquisition of cancer biotech Day One Biopharmaceuticals…